NCT04751227View on ClinicalTrials.gov

Modafinil for Wakefulness in the Critical Care Units

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

November 22, 2020

Primary Completion Date

January 30, 2021

Study Completion Date

January 30, 2021

Conditions
Critical IllnessCOVID-19Cognitive Dysfunction
Interventions
DRUG

Modafinil

100-200 mg oral daily for for Wakefulness in the Critical Care Units

Trial Locations (1)

Unknown

King Faisal Specialist Hospital and Research Center, Riyadh

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT04751227 - Modafinil for Wakefulness in the Critical Care Units | Biotech Hunter | Biotech Hunter